Marzana Chowdhury1, David Euhus2, Tracy Onega3, Swati Biswas4, Pankaj K Choudhary5. 1. Department of Mathematical Sciences, University of Texas at Dallas, 800 W Campbell Rd, FO 35, Richardson, TX, 75080, USA. 2. Division of Surgical Oncology, Johns Hopkins University, Baltimore, USA. 3. Department of Community and Family Medicine, Geisel School of Medicine at Dartmouth, Hanover, USA. 4. Department of Mathematical Sciences, University of Texas at Dallas, 800 W Campbell Rd, FO 35, Richardson, TX, 75080, USA. swati.biswas@utdallas.edu. 5. Department of Mathematical Sciences, University of Texas at Dallas, 800 W Campbell Rd, FO 35, Richardson, TX, 75080, USA. pankaj@utdallas.edu.
Abstract
PURPOSE: Patients diagnosed with invasive breast cancer (BC) or ductal carcinoma in situ are increasingly choosing to undergo contralateral prophylactic mastectomy (CPM) to reduce their risk of contralateral BC (CBC). This is a particularly disturbing trend as a large proportion of these CPMs are believed to be medically unnecessary. Many BC patients tend to substantially overestimate their CBC risk. Thus, there is a pressing need to educate patients effectively on their CBC risk. We develop a CBC risk prediction model to aid physicians in this task. METHODS: We used data from two sources: Breast Cancer Surveillance Consortium and Surveillance, Epidemiology, and End Results to build the model. The model building steps are similar to those used in developing the BC risk assessment tool (popularly known as Gail model) for counseling women on their BC risk. Our model, named CBCRisk, is exclusively designed for counseling women diagnosed with unilateral BC on the risk of developing CBC. RESULTS: We identified eight factors to be significantly associated with CBC-age at first BC diagnosis, anti-estrogen therapy, family history of BC, high-risk pre-neoplasia status, estrogen receptor status, breast density, type of first BC, and age at first birth. Combining the relative risk estimates with the relevant hazard rates, CBCRisk projects absolute risk of developing CBC over a given period. CONCLUSIONS: By providing individualized CBC risk estimates, CBCRisk may help in counseling of BC patients. In turn, this may potentially help alleviate the rate of medically unnecessary CPMs.
PURPOSE: Patients diagnosed with invasive breast cancer (BC) or ductal carcinoma in situ are increasingly choosing to undergo contralateral prophylactic mastectomy (CPM) to reduce their risk of contralateral BC (CBC). This is a particularly disturbing trend as a large proportion of these CPMs are believed to be medically unnecessary. Many BC patients tend to substantially overestimate their CBC risk. Thus, there is a pressing need to educate patients effectively on their CBC risk. We develop a CBC risk prediction model to aid physicians in this task. METHODS: We used data from two sources: Breast Cancer Surveillance Consortium and Surveillance, Epidemiology, and End Results to build the model. The model building steps are similar to those used in developing the BC risk assessment tool (popularly known as Gail model) for counseling women on their BC risk. Our model, named CBCRisk, is exclusively designed for counseling women diagnosed with unilateral BC on the risk of developing CBC. RESULTS: We identified eight factors to be significantly associated with CBC-age at first BC diagnosis, anti-estrogen therapy, family history of BC, high-risk pre-neoplasia status, estrogen receptor status, breast density, type of first BC, and age at first birth. Combining the relative risk estimates with the relevant hazard rates, CBCRisk projects absolute risk of developing CBC over a given period. CONCLUSIONS: By providing individualized CBC risk estimates, CBCRisk may help in counseling of BC patients. In turn, this may potentially help alleviate the rate of medically unnecessary CPMs.
Entities:
Keywords:
Absolute risk; Breast Cancer Surveillance Consortium; Breast density; CBCRisk; Contralateral breast cancer; SEER
Authors: Judy C Boughey; Tanya L Hoskin; Amy C Degnim; Thomas A Sellers; Joanne L Johnson; Melanie J Kasner; Lynn C Hartmann; Marlene H Frost Journal: Ann Surg Oncol Date: 2010-09-19 Impact factor: 5.344
Authors: Lisbeth Bertelsen; Leslie Bernstein; Jørgen H Olsen; Lene Mellemkjaer; Robert W Haile; Charles F Lynch; Kathleen E Malone; Hoda Anton-Culver; Jane Christensen; Bryan Langholz; Duncan C Thomas; Colin B Begg; Marinela Capanu; Bent Ejlertsen; Marilyn Stovall; John D Boice; Roy E Shore; Jonine L Bernstein Journal: J Natl Cancer Inst Date: 2007-12-25 Impact factor: 13.506
Authors: Swati Biswas; Philamer Atienza; Jonathan Chipman; Kevin Hughes; Angelica M Gutierrez Barrera; Christopher I Amos; Banu Arun; Giovanni Parmigiani Journal: Breast Cancer Res Treat Date: 2013-05-21 Impact factor: 4.872
Authors: Nehmat Houssami; Linn A Abraham; Karla Kerlikowske; Diana S M Buist; Les Irwig; Janie Lee; Diana L Miglioretti Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-03-19 Impact factor: 4.254
Authors: Michael S Shawky; Cecilia W Huo; Kara Britt; Erik W Thompson; Michael A Henderson; Andrew Redfern Journal: Breast Cancer Res Treat Date: 2019-06-08 Impact factor: 4.872
Authors: Marzana Chowdhury; David Euhus; Maureen O'Donnell; Tracy Onega; Pankaj K Choudhary; Swati Biswas Journal: Breast Cancer Res Treat Date: 2018-03-06 Impact factor: 4.872
Authors: Renée S J M Schmitz; Erica A Wilthagen; Frederieke van Duijnhoven; Marja van Oirsouw; Ellen Verschuur; Thomas Lynch; Rinaa S Punglia; E Shelley Hwang; Jelle Wesseling; Marjanka K Schmidt; Eveline M A Bleiker; Ellen G Engelhardt Journal: Cancers (Basel) Date: 2022-07-02 Impact factor: 6.575
Authors: Daniele Giardiello; Maartje J Hooning; Michael Hauptmann; Renske Keeman; B A M Heemskerk-Gerritsen; Heiko Becher; Carl Blomqvist; Stig E Bojesen; Manjeet K Bolla; Nicola J Camp; Kamila Czene; Peter Devilee; Diana M Eccles; Peter A Fasching; Jonine D Figueroa; Henrik Flyger; Montserrat García-Closas; Christopher A Haiman; Ute Hamann; John L Hopper; Anna Jakubowska; Floor E Leeuwen; Annika Lindblom; Jan Lubiński; Sara Margolin; Maria Elena Martinez; Heli Nevanlinna; Ines Nevelsteen; Saskia Pelders; Paul D P Pharoah; Sabine Siesling; Melissa C Southey; Annemieke H van der Hout; Liselotte P van Hest; Jenny Chang-Claude; Per Hall; Douglas F Easton; Ewout W Steyerberg; Marjanka K Schmidt Journal: Breast Cancer Res Date: 2022-10-21 Impact factor: 8.408
Authors: Sumadi Lukman Anwar; Dayat Prabowo; Widya Surya Avanti; Ery Kus Dwianingsih; Wirsma Arif Harahap; Teguh Aryandono Journal: Ann Med Surg (Lond) Date: 2020-11-04
Authors: Julia A Knight; Kristina M Blackmore; Jing Fan; Kathleen E Malone; Esther M John; Charles F Lynch; Celine M Vachon; Leslie Bernstein; Jennifer D Brooks; Anne S Reiner; Xiaolin Liang; Meghan Woods; Jonine L Bernstein Journal: Breast Cancer Res Date: 2018-03-22 Impact factor: 6.466
Authors: Daniele Giardiello; Ewout W Steyerberg; Michael Hauptmann; Muriel A Adank; Delal Akdeniz; Carl Blomqvist; Stig E Bojesen; Manjeet K Bolla; Mariël Brinkhuis; Jenny Chang-Claude; Kamila Czene; Peter Devilee; Alison M Dunning; Douglas F Easton; Diana M Eccles; Peter A Fasching; Jonine Figueroa; Henrik Flyger; Montserrat García-Closas; Lothar Haeberle; Christopher A Haiman; Per Hall; Ute Hamann; John L Hopper; Agnes Jager; Anna Jakubowska; Audrey Jung; Renske Keeman; Iris Kramer; Diether Lambrechts; Loic Le Marchand; Annika Lindblom; Jan Lubiński; Mehdi Manoochehri; Luigi Mariani; Heli Nevanlinna; Hester S A Oldenburg; Saskia Pelders; Paul D P Pharoah; Mitul Shah; Sabine Siesling; Vincent T H B M Smit; Melissa C Southey; William J Tapper; Rob A E M Tollenaar; Alexandra J van den Broek; Carolien H M van Deurzen; Flora E van Leeuwen; Chantal van Ongeval; Laura J Van't Veer; Qin Wang; Camilla Wendt; Pieter J Westenend; Maartje J Hooning; Marjanka K Schmidt Journal: Breast Cancer Res Date: 2019-12-17 Impact factor: 6.466